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Introduction
Diagnosis of acute cholangitis (AC) is clinical.
A definitive diagnosis cannot be established only on
the basis of laboratory tests. A history of biliary
tract disease and clinical presentation are important
elements in establishing the diagnosis. Classically,
the most important clinical manifestation is the so-
called “Charcot’s triad” (fever and/or chills, abdom-
inal pain and jaundice). According to the literature,
50-70% of patients with AC present this sympto-
matic triad, but this means that more than one-third
do not manifest all the triad components.
Laboratory data and the results of imaging studies
can provide evidence to support the diagnosis,
especially in those patients with clinical manifesta-
tions of AC, but without the full triad(1).
The pathogenesis of AC is represented by an
infection of the biliary tract associated with a par-
tial or complete obstruction of the biliary system
due to various causes (bile duct lithiasis, benign or
malignant stenosis, malfunction of biliary-enteric
anastomosis, etc.). A biliary tract infection alone
may not cause a clinically evident cholangitis, until
the biliary obstruction increases intraductal pressure
resulting in cholangio-venous or cholangio-lym-
phatic reflux(2).
Subsequently AC evolves from a localized bil-
iary infection to a systemic inflammatory response
syndrome (SIRS), and in the case of advanced dis-
ease can lead to sepsis with or without organ dys-
function. In the 1990s mortality rates in severe
cases of AC ranged from 11 to 27%, and even now
severe forms of AC may be fatal if proper treatment
is not received(3,4).
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case of a 69-year-old man with recurrent postoperative (laparoscopic cholecystectomy) biliary stricture-related mild acute cholan-
gitis, with presence of biliary sludge in the common bile duct, previously diagnosed by gastroenterologists as acute drug-induced
hepatotoxicity. After broad-spectrum antibiotic i.v. therapy the patient subsequently underwent endoscopic retrograde cholangio-
pancreatography (ERCP), with stent placement, and symptoms and laboratory abnormalities disappeared.
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Here we report the case of a 69-year-old man,
admitted to our Internal Medicine Department, suf-
fering from recurrent postoperative (laparoscopic
cholecystectomy) biliary stricture-related mild
acute cholangitis, with presence of biliary sludge in
the common bile duct, previously diagnosed by
gastroenterologists as acute drug-induced hepato-
toxicity. After broad-spectrum antibiotic i.v. therapy
the patient subsequently underwent endoscopic ret-
rograde cholangio-pancreatography (ERCP), with
stent placement, with resolution of symptoms and
laboratory abnormalities.
Case presentation
A 69-year-old man was admitted to our
Department of Internal Medicine with night fever.
On admission the patient was pyretic (axillary tem-
perature 38.8°C), with pale and dehydrated skin and
mucous membranes, soft abdomen with tenderness
on deep palpation in the hypo-gastric region, nor-
mal bowel sounds. Blood tests showed leucocyto-
sis: white blood cells (WBC) 15.200/mmc, neu-
trophils 93%, increased hepatic cytolysis: aspartate
aminotransferase (AST) 855 IU/ml, reference val-
ues 0-37, alanine aminotransferase (ALT) 481
IU/ml, reference values 0-41, and cholestasis
indices: alkaline phosphatase (ALP) 669 IU/ml, ref-
erence values 40-19, gamma-glutamyl transpepti-
dase (γ-GT) 552 IU/ml, reference values 8-61,
total/direct bilirubin 1.97/1.26 mg/dl, reference val-
ues 0.67-1.17/<0.3, and presence of nitrates, bac-
teriuria and leucocyturia in the urinalysis. A whole-
body Computerized Tomography (CT) scan, per-
formed urgently, showed “modest aerobilia and
prevalence of left hepatic sections with outcome of
cholecystectomy, bladder lithiasis and fecaloma in
rectal ampulla”. About a week before admission
and 3 months before, the patient was hospitalized in
a Department of Gastroenterology, with the same
symptoms, and discharged with the diagnosis of
“acute drug-induced hepatotoxicity” secondary to
oral assumption of home antibiotic therapy with
penicillin and macrolides to treat a urinary tract
infection; during these hospitalizations a “sponta-
neous” reduction of fever and liver function tests
occurred.
Patient’s medical history revealed the follow-
ing. In 1976 a diagnosis of pineal tumor associated
with triventricular hydrocephalus, underwent place-
ment of ventricular-peritoneal shunt and subsequent
surgical excision of the tumor and cobalt therapy.
In 2001 diagnosis of Parkinson’s disease with
vascular genesis. In 2006 received an indwelling
bladder catheter due to diagnosis of prostatic hyper-
trophy with urinary incontinence and recurrent uri-
nary tract infections. In 2007 arterial hypertension
was diagnosed, and in the same year he was admit-
ted to hospital for “obstructive jaundice”, then sub-
mitted to laparoscopic cholecystectomy for biliary
lithiasis. During the hospitalization in our
Department, broad-spectrum antibiotic i.v. therapy
with piperacillin/tazobactam plus levofloxacin was
carried out followed by defervescence and resolu-
tion of leucocytosis (GB 7.250/mmc, neutrophils
67%). Moreover, since the patient had not reported
home use of drugs and in relation to previous
laparoscopic cholecystectomy, despite the absence
of typical AC symptoms (i.e. upper abdominal pain
and jaundice), a mechanical obstruction of the bile
flow was suspected. Therefore, cholangio-nuclear
magnetic resonance was performed showing “mild
dilatation of the intra-hepatic bile ducts and of the
common bile duct (1.0 cm), as in the presence of
gallstones and biliary sludge”.
The patient then underwent endoscopic retro-
grade cholangio-pancreatography (ERCP), which
showed a “scar-like sub-stenosis of the papilla of
Vater,” which was dilated with spontaneous leakage
of biliary sludge from the common bile duct, and in
which a stent was placed. After the endoscopic
treatment, indices of hepatic cytolysis and cholesta-
sis returned to normal range, with the exception of
the γ-GT value (125 IU/ml), which normalized after
three months. Therefore we reached a final diagno-
sis of postoperative (laparoscopic cholecystectomy)
biliary stricture-related mild acute cholangitis, with
presence of biliary sludge in the common bile duct. 
Discussion
Patients with AC are at risk of developing seri-
ous infections that can be fatal if appropriate treat-
ment is not received promptly. Unlike other dis-
eases, such as acute cholecystitis or diverticulitis,
there is no organ or tissue through which the defini-
tive diagnosis can be reached through histology.
Therefore, a diagnostic gold standard must be
established using other methods. The update of
“Diagnostic criteria and assessment of severity of
AC: Tokyo Guidelines” in 2007 (TG07), with the
new criteria (TG13), improved sensitivity and
specificity in the diagnosis of this disease and
allows an early assessment of severity, assuming
that biliary drainage or other surgical procedures
can be performed immediately(5).
The three main criteria used in the diagnosis
of AC are shown in Table 1.
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A. Systemic inflammation
A-1. Fever and/or shaking chills
A-2. Laboratory data: evidence of inflammatory response
B. Cholestasis
B-1. Jaundice
B-2. Laboratory data: abnormal liver function tests
C. Imaging
C-1. Biliary dilatation
C-2. Evidence of the etiology on imaging (stricture, stone, stent, etc.)
Suspected diagnosis: one item in A, + one item in either B or C.
Definite diagnosis: one item in A, one item in B, and one item in C
A-2 Abnormal white blood cell counts, increase of serum C-reactive protein levels, and other changes
indicating inflammation
B-2 Increased serum γ-GT, ALP, AST and ALT levels
Thresholds
A-1 Fever BT >38°C
A-2 Evidence of inflammatory response WBC (x1.000/µL)CRP (mg/dL) 
<4 or >10
≥1 
B-1 Jaundice T-Bil (mg/dL) ≥2 
B-2 Abnormal liver function tests 
ALP (IU/ml) 
γ-GT (IU/ml)
AST (IU/ml)
ALT (IU/ml)
>1.5 x STD*
>1.5 x STD*
>1.5 x STD*
>1.5 x STD*
Other factors which are helpful in the diagnosis of acute cholangitis include abdominal pain (right upper quadrant or upper abdomi-
nal) and a history of biliary disease, such as gallstones, previous procedures, and placement of a biliary stent.
In acute hepatitis, marked systemic inflammatory response is observed infrequently. Virology and serological tests are required when
differential diagnosis is difficult.
γ-GT: γ-glutamyltransferase; ALP: alkaline phosphatase; 
AST: aspartate aminotransferase; ALT: alanine aminotransferase
BT: body temperature; WBC: white blood cells; 
CRP: C-reactive protein; T-Bil: total bilirubin;
STD*: upper limit of normal value
From: Kiriyama S, Takada T, Strasberg SM, et al. Tokyo Guidelines Revision Committee. New diagnostic criteria and severity asses-
sment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci 2012; 19: 548-56. (modified)
Table 1: Tokyo Guidelines version 13 (TG13) diagnostic criteria for acute cholangitis.
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GRADE III - Severe acute cholangitis
“Grade III” acute cholangitis is defined as acute cholangitis that is associated with the
onset of dysfunction in at least one of any  the following organs/systems
1. Cardiovascular dysfunction 
Hypotension requiring dopamine ≥5µg/Kg per min, 
or any dose of norepinephrine
2. Neurological dysfunction Disturbance of consciousness
3. Respiratory dysfunction PaO2/FiO2 <300
4. Renal dysfunction Oliguria, serum creatinine >2.0 mg/dL
5. Hepatic dysfunction INR >1.5 
6. Hematological dysfunction Platelet count<100.000 mm3
GRADE II - Moderate acute cholangitis
“Grade II” acute cholangitis is associated with any two of the following conditions
1. Abnormal WBC count (>12.000 mm3, <4.000 mm3)
2. High fever (≥39 °C)
3. Age (>75 years)
4. Hyperbilirubinemia (T-Bil ≥5mg/dL)
5. Hypoalbuminemia (<STD* x 0.7)
GRADE I - Mild acute cholangitis
“Grade I” acute cholangitis does not meet the criteria of “Grade III” (severe) or “Grade
II” (moderate) acute cholangitis at initial diagnosis 
Table 2: Tokyo Guidelines version 13 (TG13) severity assessment criteria for
acute cholangitis.
Early diagnosis, early biliary drainage and/or treatment for etiology, and antimicrobial administration are fundamental treatments for
acute cholangitis classified not only “Grade III” (severe) and “Grade II” (moderate) but also “Grade I” (mild).
Therefore it is recommended that patients with acute cholangitis who do not respond to the initial medical treatment (general suppor-
tive care and antimicrobial therapy) undergo early biliary drainage or treatment for etiology.
PaO2: partial pressure of oxygen in the blood; FiO2: fractional inspired concentration of oxygen;
INR: International Normalized Ratio; WBC: white blood cells; T-Bil: total bilirubin;
STD*: upper limit of normal value
From: Kiriyama S, Takada T, Strasberg SM, et al. Tokyo Guidelines Revision Committee. New diagnostic criteria and severity asses-
sment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci 2012; 19: 548-56. (modified)
The diagnosis is suspected when there is an
element in A, plus an element in B or in C, and con-
firmed if an element is present both in A, in B and
in C. In our case, the episode of AC due to biliary
outflow obstruction, secondary to postoperative bil-
iary strictures (POBS), was suspected not only
because of systemic inflammatory response and
laboratory data, but also thanks to important anam-
nesis information: the previous laparoscopic chole-
cystectomy. This procedure is considered by the
Tokyo 2013 guidelines as another useful factor in
the diagnosis of AC. 
Laparoscopic surgery has spread rapidly and
has been applied not only to the gastrointestinal
tract, but also the liver, gallbladder, and pancreas.
Laparoscopic surgery was initially applied to chole-
cystectomy, and laparoscopic cholecystectomy is a
standard operation at present. However, it is well
known that the transition, since the 90s, from
“open” cholecystectomy to laparoscopic has been
associated with a significant increase in POBS fre-
quency(6,7). According to some studies, postoperative
benign bile duct strictures occur in 0.2 to 0.6% of
cases after laparoscopic biliary tract surgery(8). In
addition it has been reported that after laparoscopic
cholecystectomy for cholelithiasis, the recurrence
of common bile duct lithiasis is around 2.5%(9).
Several studies argue that POBS adversely and sig-
nificantly affect the patient’s quality of life and are
a common cause of lawsuits relating to medical
negligence(10,11).
Thanks to improved and increased training in
the technique of laparoscopic cholecystectomy,
these lesions have become infrequent, but have not
disappeared and when they occur, a multidiscipli-
nary approach is essential to ensure the best out-
come(12). The median delay in POBS diagnosis may
be months or years, and the belated presentation
includes recurrent episodes of AC, as in our case,
previously diagnosed as acute drug-induced hepato-
toxicity, and secondary biliary cirrhosis(13).
POBS are often identified by endoscopy during
ERCP for known or suspected lesions of the biliary
tract. When there is strong suspicion of biliary com-
plications, ERCP can be performed immediately
after the surgery, or months or years later when a
delayed stenosis appears with abnormal liver func-
tion values, dilated bile ducts or both(14). The stenotic
outcome of laparoscopic cholecystectomy is a diffi-
cult problem to manage. The standard radiological
percutaneous and surgical treatments result in sig-
nificant morbidity(12).
Consequently interest in alternative therapies
to surgery has recently appeared(15,16). Endoscopic
dilatation of the postoperative biliary strictures,
with or without stent placement, was firstly
described by Costamagna et al. in 2001(17). Many
studies considered this surgical technique of dilata-
tion with stent to be less invasive(18,19). In the
Yasuhisa et al. study, endoscopic treatment was
associated with low morbidity and excellent long-
term outcome. In addition the after-surgery recur-
rence of the stenosis was only 5% (1/21) during a
mean follow-up of more than 120 months(20). In
other studies on the endoscopic management of
postoperative stenosis of the bile duct, the success
rate varied from 68-89%(18,19,21).
Therefore, the widespread and improved skills
of biliary endoscopy have led to a reduction in mor-
bidity and mortality from POBS-related AC.
Nevertheless AC remains a potentially fatal disease
and early identification of the severity is necessary
to choose an appropriate therapy, surgery in particu-
lar. The Tokyo 2013 guidelines (see Table 2) allow
the early assessment of disease severity on admis-
sion, assuming that biliary drainage or other proce-
dures can be carried out rapidly. According to these
criteria patients who fall into the moderate or
severe category would be candidates for urgent
decompression of the biliary tract, while those in
the mild category would be initially treated with
antibiotics. Many patients in the latter category
should undergo biliary drainage within the first 48h,
to control the origin of the AC, such as stenosis of
the papilla, and extract stones or biliary sludge
within the common hepatic duct(5), as our case
report has described.
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